Surrozen to Present at the 41st Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”)…

Counter-rotating fates

Tokyo, Japan – As anyone who drinks their coffee with milk knows, it’s much easier to…

Blood pressure drug holds promise for treating PTSD

AUGUSTA, Ga. (Jan. 5, 2023) – There is new evidence that a 50-year-old blood pressure drug…

Shockwave Medical Provides Quarterly Earnings Release Dates for 2023

SANTA CLARA, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer…

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 31 d?cembre 2022

Last Updated on January 4, 2023 by GlobeNewsWire Information mensuelle relative au nombre total des droits…

Celularity Appoints Paul Graves as Chief Communications Officer

Veteran executive brings more than 30 years of biopharmaceutical public relations and public affairs experience Veteran…

DICE Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — DICE Therapeutics, Inc. (Nasdaq: DICE), a…

OpGen Announced 1-for-20 Reverse Stock Split

ROCKVILLE, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”),…

Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2022

Last Updated on January 4, 2023 by GlobeNewsWire Monthly information regarding the total number of voting…

NIH study links specific outdoor air pollutants to asthma attacks in urban children

Moderate levels of two outdoor air pollutants, ozone and fine particulate matter, are associated with non-viral…

NFL BIOSCIENCES : nombre d’actions et droits de vote au 31.12.2022

NOMBRE D’ACTIONS ET DROITS DE VOTE COMPOSANT LE CAPITAL The post NFL BIOSCIENCES : nombre d’actions…

Umoja Biopharma to Present at the 41st Annual J.P. Morgan Healthcare Conference

SEATTLE, Jan. 04, 2023 (GLOBE NEWSWIRE) — Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated…

Will the Shifting Landscape of NGS Disrupt Genomics?

Broadcast Date: January 18, 2023Time: 8:00 am PT, 11:00 am ET, 17:00 CET   REGISTER NOW   2022 saw…

More links aren’t necessarily better for hybrid nanomaterials

HOUSTON – (Jan. 4, 2023) – Chemists from Rice University and the University of Texas at…

New projects highlight UTA’s ‘exceptional’ ability to innovate

Three faculty members in the Mechanical and Aerospace Engineering Department at The University of Texas at…

Illinois Tech assistant professor awarded funding to stop spread of ‘forever chemicals’ into waterways

CHICAGO—January 4, 2023—Illinois Institute of Technology (Illinois Tech) Assistant Professor David Lampert was recently awarded funding by the U.S. Environmental…

Researchers detect fluoride in water with new simple color change test

Environmental contaminants like fluoride, lead and pesticides exist all around and even within us. While researchers…

Vericel to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023

CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies…

Next-generation wireless technology may leverage the human body for energy

January 4, 2023 Credit: Cui et al., 10.1145/3560905.3568526 January 4, 2023 Next-generation Wireless Technology May Leverage…

Argonne researchers win defense programs award for nuclear safety work

Award recognizes work carried out in collaboration with Lawrence Livermore National Laboratory researchers to secure America’s…

Jasper Therapeutics Announces European Union Orphan Drug Designation for Briquilimab as a Conditioning Treatment for Patients Prior to Receiving a Stem Cell Transplant

REDWOOD CITY, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology…

Cidara Therapeutics Nominates First Oncology Clinical Development Candidate from its Cloudbreak(R) Platform

CBO-212 is a first-in-class inhibitor of CD73 cancer immunotherapy target CBO-212 is a first-in-class inhibitor of…

Akari Therapeutics to Present at Biotech Showcase(TM) 2023

NEW YORK and LONDON, Jan. 04, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a…

Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference

Dyadic’s executive management to attend the J.P. Morgan 41st Annual Healthcare Conference and the 6th Annual…

Ceapro Announces Grant of Stock Options

EDMONTON, Alberta, Jan. 04, 2023 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or…

Checkpoint Therapeutics Submits Biologics License Application to FDA for Cosibelimab as a Treatment for Patients with Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Positive and clinically meaningful pivotal clinical results announced in 2022 in both metastatic and locally advanced…

Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference

DURHAM, N.C., Jan. 04, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader in…

CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery and Development Capability

PRESS RELEASE The post CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery…

Coherus BioSciences Management to Present at the 41st Annual J.P. Morgan Healthcare Conference

REDWOOD CITY, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today…

Voyager Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company…